The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 16, 2014
Filed:
Nov. 15, 2010
Ramakrishna Nirogi, Hyderabad, IN;
Anil Karbhari Shinde, Hyderabad, IN;
Ramasastri Kambhampati, Hyderabad, IN;
Rambabu Namala, Hyderabad, IN;
Adi Reddy Dwarampudi, Hyderabad, IN;
Laxman Kota, Hyderabad, IN;
Murlimohan Gampa, Hyderabad, IN;
Padmavathi Kodru, Hyderabad, IN;
Taraka Naga Vinaykumar Tiriveedhi, Hyderabad, IN;
Vishwottam Nagaraj Kandikere, Hyderabad, IN;
Nageshwara Rao Muddana, Hyderabad, IN;
Ramanatha Shrikantha Saralaya, Hyderabad, IN;
Pradeep Jayarajan, Hyderabad, IN;
Dhanalakshmi Shanmuganathan, Hyderabad, IN;
Ishtiyaque Ahmad, Hyderabad, IN;
Venkateswarlu Jasti, Hyderabad, IN;
Ramakrishna Nirogi, Hyderabad, IN;
Anil Karbhari Shinde, Hyderabad, IN;
Ramasastri Kambhampati, Hyderabad, IN;
Rambabu Namala, Hyderabad, IN;
Adi Reddy Dwarampudi, Hyderabad, IN;
Laxman Kota, Hyderabad, IN;
Murlimohan Gampa, Hyderabad, IN;
Padmavathi Kodru, Hyderabad, IN;
Taraka Naga Vinaykumar Tiriveedhi, Hyderabad, IN;
Vishwottam Nagaraj Kandikere, Hyderabad, IN;
Nageshwara Rao Muddana, Hyderabad, IN;
Ramanatha Shrikantha Saralaya, Hyderabad, IN;
Pradeep Jayarajan, Hyderabad, IN;
Dhanalakshmi Shanmuganathan, Hyderabad, IN;
Ishtiyaque Ahmad, Hyderabad, IN;
Venkateswarlu Jasti, Hyderabad, IN;
Suven Life Sciences Limited, Hyderabad, IN;
Abstract
The present invention relates to heterocyclyl compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds of formula (I) are useful in the treatment of various disorders that are related to Histamine Hreceptors, for example cognitive disorders, sleep disorders, obesity and pain.